Myosin-actin motors: the partnership goes atomic

Structure-function analysis of the motor domain of myosin

Motor proteins perform a wide variety of functions in all eukaryotic cells. Recent advances in the structural and mutagenic analysis of the myosin motor has led to insights into how these motors transduce chemical energy into mechanical work. This review focuses on the analysis of the effects of myosin mutations from a variety of organisms on the in vivo and in vitro properties of this ubiquitous motor and illustrates the positions of these mutations on the high-resolution three-dimensional structure of the myosin motor domain.

Structure-function studies of the myosin motor domain: importance of the 50-kDa cleft

We used random mutagenesis to create 21 point mutations in a highly conserved region of the motor domain of Dictyostelium myosin and classified them into three distinct groups based on the ability to complement myosin null cell phenotypes: wild type, intermediate, and null. Biochemical analysis of the mutated myosins also revealed three classes of mutants that correlated well with the phenotypic classification. The mutated myosins that were not fully functional showed defects ranging from ATP nonhydrolyzers to myosins whose enzymatic and mechanical properties are uncoupled. Placement of the mutations onto the three-dimensional structure of myosin showed that the mutated region lay along the cleft that separates the active site from the actin-binding domain and that has been shown to move in response to changes at the active site. These results demonstrate that this region of myosin plays a key role in transduction of chemical energy to mechanical displacement.

Muscle growth and muscle function: a molecular biological perspective

Molecular biological methods are pervading all biomedical fields and it is likely that they will soon introduce new techniques to veterinary diagnostics and have a major impact on food and fibre production in animal agriculture. The ability to manipulate muscle growth and phenotype will present new ethical problems, particularly if the techniques are used to manipulate muscle development in greyhounds and racehorses where the financial rewards could be very substantial. Muscle has been a useful tissue for the study of the molecular control of tissue development because terminal differentiation results in the production of large quantities of highly specialised proteins. Now that the functional anatomy of structural genes in muscle is being elucidated, a coherent picture is beginning to emerge of the way in which post-natal muscle growth and phenotype are regulated at the gene level. The hormones and growth factors involved in regulating the quantitative and qualitative changes in gene expression are now better understood, together with the ability of the tissue to adapt to physical signals and hence new activity patterns. The myosin heavy chain isoform genes which encode the myosin cross-bridges (the force generators for muscular contraction) exist as a large multigene family. The contractility and other characteristics of muscle depend to a large extent on the differential expression of members of this and other gene families. Muscle fibres adapt for increased power output by expressing a subset of "fast' genes and for increased economy of action by expressing a slow subset of genes and producing more mitochondria. With the increasing understanding of gene expression in muscle, there are prospects for manipulating the mass, contractility and other characteristics of muscle and also to change its phenotype and understand certain disease states.

Myosin structure/function: a combined mutagenesis-crystallography approach

In the past year, the structure of the regulatory domain of scallop myosin has joined that of the chicken skeletal muscle myosin subfragment 1 and provided insights into the regulation of myosin function. Mutagenesis studies in a variety of systems have used the information provided by these structures to create mutant myosins to test models of chemomechanical transduction and its regulation.

Actin and the actomyosin interface: a review

This review deals with the structure of the actin monomer, its assembly into filaments and the loci on F-actin involved in binding myosin. Two distinctly different arrangements of monomers have been suggested for actin filaments. One model proposed by Holmes et al. is well developed. It places the so-called 'large' domain close to the filament axis and the so-called 'small' domain out near the surface of the filament. A second, less-well developed, model proposed by Schutt et al. locates the 'small' domain close to the filament axis and they rotate the monomer so that 'bottom' of the 'large' domain is at the highest radius. We analyze the available evidence for the models of F-actin derived from X-ray diffraction, reconstructions from electron micrographs, fluorescence resonance energy transfer spectroscopy, chemical cross-linking, antibody probes, limited proteolysis, site-directed and natural mutations, nuclear magnetic resonance spectroscopy and other techniques. The result is an actin-centered view of the loci on actin which are probably involved in its interaction with the myosin 'head'. From these multiple contacts we speculate on the sequence of steps between the initial weak-binding state of S-1 to the actin filament through to the stable strong-binding state seen in the absence of free Mg-ATP, i.e., the rigor state.